Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
Autonomix Medical, Inc. announced the issuance of a new U.S. patent expanding its intellectual property protections for its technology that senses, maps, and selectively targets nerves related to tumors, cancer pain, and autonomic nervous system disorders. The patent covers minimally invasive systems that aid in targeted treatment using neural mapp…